mr mkt got it right, those in the know of course. $351m impairments.....expected as much given mkt cap.
$1bn net equity now on BS, and we sit on a mkt cap of $750m - difference being the debt. almost spot on....
as others have said, clean slate now, competition popping up all over our generics products, so expect continued softening in that division.....nothing new on timing of new product launches, just the usual on "sometime in FY20"....
expect the usual short term adjustments to sp, but now that the purge is complete, greenville facility in a better steady state, should be a good medium play. decent operating cashflows of $56m every half....hope this grows. positive is the debt pay down, small dent, but progress.
MYX Price at posting:
47.5¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)